Silver Oak Securities Incorporated Makes New Investment in ALPS Medical Breakthroughs ETF $SBIO

Silver Oak Securities Incorporated acquired a new position in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) in the 4th quarter, HoldingsChannel reports. The firm acquired 13,335 shares of the company’s stock, valued at approximately $677,000.

Other institutional investors also recently modified their holdings of the company. Jones Financial Companies Lllp acquired a new position in shares of ALPS Medical Breakthroughs ETF in the 1st quarter worth approximately $782,000. Ally Invest Advisors Inc. bought a new stake in ALPS Medical Breakthroughs ETF during the 2nd quarter worth approximately $200,000. Raymond James Financial Inc. acquired a new stake in ALPS Medical Breakthroughs ETF during the 2nd quarter valued at $82,000. Moran Wealth Management LLC increased its holdings in ALPS Medical Breakthroughs ETF by 72.2% during the 3rd quarter. Moran Wealth Management LLC now owns 17,187 shares of the company’s stock valued at $668,000 after purchasing an additional 7,206 shares in the last quarter. Finally, Sterling Investment Advisors Ltd. bought a new position in ALPS Medical Breakthroughs ETF in the 3rd quarter valued at $315,000.

ALPS Medical Breakthroughs ETF Price Performance

ALPS Medical Breakthroughs ETF stock opened at $52.86 on Thursday. The business’s fifty day moving average is $50.84 and its two-hundred day moving average is $47.66. ALPS Medical Breakthroughs ETF has a 52 week low of $22.33 and a 52 week high of $54.79.

ALPS Medical Breakthroughs ETF Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.